Clorox (NYSE: CLX) reported Q1 EPS of $3.22, $0.90 better than the analyst estimate of $2.32. Revenue for the quarter came in at $1.92 billion versus the consensus estimate of $1.76 billion.

"We delivered another quarter of outstanding results to have a strong start to the fiscal year, with broad-based strength across our portfolio, driving double-digit sales growth in all reportable segments," said CEO Linda Rendle. "At a time of global uncertainty, these results speak to the strength of our brands and passion of our people as they stepped up to meet the needs of consumers around the world. Moving forward, we'll drive our momentum by leaning into our IGNITE strategy. We'll invest strongly in superior brand experiences and strategic growth initiatives in support of our ambition of accelerating long-term profitable growth for the company."

Added Rendle: "Our priority remains maximizing the supply of our products — leveraging all available resources to help ensure people can access what they need — and continuing to play 100% offense on all our businesses, with a focus on delivering value and innovation that allows us to convert new users to loyal consumers."

GUIDANCE:

Clorox sees FY2021 EPS of $7.70-$7.95, versus the consensus of $7.69.

For earnings history and earnings-related data on Clorox (CLX) click here.